BSE · HEMORGANIC
Hemo Organic Limited (HEMORGANIC) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,275
of 5,054 stocks
🏆 New peak
▲ 3711W▲ 4251M
Peak #4,275 · 22 Oct 2026
Operating in Capital Goods, Hemo Organic Limited trades at an undemanding earnings multiple, is seeing revenue contract sharply, and has a subdued return on equity.
Market Cap
15.77 Cr
P/E Ratio
10.25
P/B Ratio
60.45
ROE
-585.48%
ROCE
-17.34%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 1.43 Cr | Rs 0 | 92.70 L | Rs 0 |
| Net Profit | Rs 53,000 | -7.42 L | -50.57 L | -15.58 L |
| EPS | 0.01 | 0.21 | 1.46 | 0.45 |
| Operating Profit | Rs 53,000 | -7.42 L | -29.69 L | -4.57 L |
Shareholding pattern
Promoter
16.85%
Public
83.15%
PUBLIC BREAKDOWN
Individuals
72.20%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Other Capital Goods stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.